⚕ GalenOps CRO console
← 704 (USA)

704-1017

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 704 (USA) (Dr. Tanaka) · consented 2013-10-06
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild CARDIAC DISORDER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-01 (study day 27.0); relationship: NONE

mild assessed 2026-08-18

Mild INFLUENZA — outcome: RECOVERED/RESOLVED; onset 2013-11-01 (study day 27.0); relationship: NONE

mild assessed 2026-08-18

Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-19 (study day 14.0); relationship: NONE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild VENTRICULAR SEPTAL DEFECT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-19 (study day 14.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.